enVVeno Medical Corporation Company Profile
NASDAQ: NVNOHealth CareMedical/Dental InstrumentsUSD
Market open · Delayed 15 min · as of Oct 9, 10:14 AM ET
enVVeno Medical at a glance
enVVeno Medical Corporation (NASDAQ: NVNO) is a Medical/Dental Instruments company in the Health Care sector headquartered in Irvine, CA. enVVeno Medical is led by Mr. Robert A. Berman and employs about 33 people. The company's shares have traded publicly since 2018.
At a market capitalization of $5.7 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001661053, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does enVVeno Medical do?
enVVeno Medical Corporation, a medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease in the United States. The company's lead product is the VenoValve, a surgical replacement venous valve for the treatment of venous chronic venous insufficiency. Its VenoValve implanted into the femoral vein of the patient in an open surgical procedure via a 5-to-6-inch incision in the upper thigh. The company also develops enVVe, a non-surgical and transcatheter-based replacement venous valve system consisting of the enVVe valve, enVVe delivery system, and delivery system accessories. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.
Business description based on the company's public filings.
Company information
- Legal name
- enVVeno Medical Corporation
- Ticker
- NASDAQ: NVNO
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- CEO
- Mr. Robert A. Berman
- Employees
- 33
- Headquarters
- 70 Doppler, Irvine, CA, United States
- Phone
- 949 261 2900
- Website
- envveno.com
- IPO year
- 2018
- Market cap
- $5.68M
- SEC CIK
- 0001661053
- Latest annual report
- 10-K · Mar 26, 2026
Companies similar to enVVeno Medical
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| SNOASonoma Pharmaceuticals Inc. | 1.19 | +2.46% | $5.69M | vs NVNO |
| VVOSVivos Therapeutics Inc. | 0.1581 | +5.75% | $5.31M | vs NVNO |
| INBSIntelligent Bio Solutions Inc. | 1.60 | +1.91% | $5.31M | vs NVNO |
| AMIXAutonomix Medical Inc. | 3.12 | -0.34% | $6.11M | vs NVNO |
| ICCMIceCure Medical Ltd. | 1.13 | -0.77% | $5.22M | vs NVNO |
| WOKWORK Medical Technology Group LTD Class A | 1.55 | +1.97% | $6.92M | vs NVNO |
| CODXCo-Diagnostics Inc. | 1.09 | +0.04% | $7.61M | vs NVNO |
| BJDXBluejay Diagnostics Inc. | 0.8034 | -1.50% | $3.59M | vs NVNO |